Paper27782834
Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S and 4 others. J Exp Clin Cancer Res, 2016. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens. Papers, record 27782834. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/27782834
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Breast Neoplasms | Major topic |
| Dendritic Cells | Major topic |
| T-Lymphocytes | Major topic |
| Cancer Vaccines | |
| Cells, Cultured | |
| Female | |
| Humans | |
| Immunotherapy | |
| Interferon-gamma | |
| Interleukin-10 | |
| Interleukin-12 | |
| Interleukin-4 | |
| Lactic Acid | |
| Nanoparticles | |
| Particle Size | |
| Polyglycolic Acid | |
| Polylactic Acid-Polyglycolic Acid Copolymer |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15560948 | Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. | Adv Drug Deliv Rev | 2005 | https://conductscience.org/library/papers/15560948 | PubMed |
| 2 | 15479436 | Vaccines that facilitate antigen entry into dendritic cells. | Immunol Cell Biol | 2004 | https://conductscience.org/library/papers/15479436 | PubMed |
| 3 | 23201055 | Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation. | Eur J Pharm Biopharm | 2013 | https://conductscience.org/library/papers/23201055 | PubMed |
| 4 | 20085824 | Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies. | Nanomedicine | 2010 | https://conductscience.org/library/papers/20085824 | PubMed |
| 5 | 15522656 | Part I: Vaccines for solid tumours. | Lancet Oncol | 2004 | https://conductscience.org/library/papers/15522656 | PubMed |
| 6 | 10840197 | Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination. | Eur J Pharm Biopharm | 2000 | https://conductscience.org/library/papers/10840197 | PubMed |
| 7 | 15771591 | Cell biology of antigen processing in vitro and in vivo. | Annu Rev Immunol | 2005 | https://conductscience.org/library/papers/15771591 | PubMed |
| 8 | 15093554 | Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer. | Clin Immunol | 2004 | https://conductscience.org/library/papers/15093554 | PubMed |
| 9 | 21679733 | Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations. | Adv Drug Deliv Rev | 2011 | https://conductscience.org/library/papers/21679733 | PubMed |
| 10 | 19306994 | Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro. | Cell Immunol | 2009 | https://conductscience.org/library/papers/19306994 | PubMed |
| 11 | 12559806 | Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro. | Vaccine | 2003 | https://conductscience.org/library/papers/12559806 | PubMed |
| 12 | 15340416 | Cancer immunotherapy: moving beyond current vaccines. | Nat Med | 2004 | https://conductscience.org/library/papers/15340416 | PubMed |
| 13 | 19093773 | Randomized clinical studies of anti-tumor vaccination: state of the art in 2008. | Expert Rev Vaccines | 2009 | https://conductscience.org/library/papers/19093773 | PubMed |
| 14 | 14639362 | The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. | Surgery | 2003 | https://conductscience.org/library/papers/14639362 | PubMed |
| 15 | 16225767 | Breast cancer immunotherapy. | Cell Mol Immunol | 2004 | https://conductscience.org/library/papers/16225767 | PubMed |
| 16 | 19186176 | Nanoparticle-based targeted drug delivery. | Exp Mol Pathol | 2009 | https://conductscience.org/library/papers/19186176 | PubMed |
| 17 | 17217312 | Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. | Mol Pharm | 2007 | https://conductscience.org/library/papers/17217312 | PubMed |
| 18 | 15821885 | Recent advances in dendritic cell biology. | J Clin Immunol | 2005 | https://conductscience.org/library/papers/15821885 | PubMed |
| 19 | 20692374 | Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy. | Nanomedicine | 2011 | https://conductscience.org/library/papers/20692374 | PubMed |
| 20 | 26042126 | Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models. | Front Immunol | 2015 | https://conductscience.org/library/papers/26042126 | PubMed |
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42193291 | Immunomodulatory Nanomaterials: Design Strategies, Mechanisms, Biomedical Applications, and Future Perspectives. | Biomedicines | 2026 | https://conductscience.org/library/papers/42193291 | PubMed |
| 41439959 | PLGA Nanoencapsulation Enhances Immunogenicity of Heat-Shocked Melanoma Tumor Cell Lysates. | Cells | 2025 | https://conductscience.org/library/papers/41439959 | PubMed |
| 41281637 | Overcoming barriers in primary bone cancer: Nanomaterial-enabled immunotherapy. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41281637 | PubMed |
| 41127507 | Immunomodulatory Mechanisms of Chronic Wound Healing: Translational and Clinical Relevance. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/41127507 | PubMed |
| 40568589 | Silica-calcium phosphate nanoparticles delivering recombinant influenza hemagglutinin DNA can induce long-lasting T cell immune cross-protection in mice. | Front Immunol | 2025 | https://conductscience.org/library/papers/40568589 | PubMed |
| 40281721 | Current and Near-Future Technologies to Quantify Nanoparticle Therapeutic Loading Efficiency and Surface Coating Efficiency with Targeted Moieties. | Bioengineering (Basel) | 2025 | https://conductscience.org/library/papers/40281721 | PubMed |
| 39600709 | Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment. | Front Immunol | 2024 | https://conductscience.org/library/papers/39600709 | PubMed |
| 39051512 | Dysfunction of dendritic cells in tumor microenvironment and immunotherapy. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/39051512 | PubMed |
| 38427275 | PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy. | Drug Deliv Transl Res | 2024 | https://conductscience.org/library/papers/38427275 | PubMed |
| 37312116 | Nanomaterials in tumor immunotherapy: new strategies and challenges. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37312116 | PubMed |
| 37240369 | Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37240369 | PubMed |
| 36980527 | The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer-Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980527 | PubMed |
| 35424648 | Utilization of metal or non-metal-based functional materials as efficient composites in cancer therapies. | RSC Adv | 2022 | https://conductscience.org/library/papers/35424648 | PubMed |
| 34902729 | Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. | Biomaterials | 2022 | https://conductscience.org/library/papers/34902729 | PubMed |
| 33898169 | Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/33898169 | PubMed |
| 33613696 | Methotrexate enhances antigen presentation and maturation of tumour antigen-loaded dendritic cells through NLRP3 inflammasome activation: a strategy for dendritic cell-based cancer vaccine. | Ther Adv Med Oncol | 2021 | https://conductscience.org/library/papers/33613696 | PubMed |
| 30871158 | Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30871158 | PubMed |
| 30607155 | Current Approaches in Development of Immunotherapeutic Vaccines for Breast Cancer. | J Breast Cancer | 2018 | https://conductscience.org/library/papers/30607155 | PubMed |
| 30604321 | Evaluation of a Particulate Breast Cancer Vaccine Delivered via Skin. | AAPS J | 2019 | https://conductscience.org/library/papers/30604321 | PubMed |
| 30312721 | Biomaterials for vaccine-based cancer immunotherapy. | J Control Release | 2018 | https://conductscience.org/library/papers/30312721 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CD80 | 941 | PubTator's text mining | https://conductscience.org/library/genes/941 | NCBI Gene |
| CD83 | 9308 | PubTator's text mining | https://conductscience.org/library/genes/9308 | NCBI Gene |
| CD86 | 942 | PubTator's text mining | https://conductscience.org/library/genes/942 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| CSF2 | 1437 | PubTator's text mining | https://conductscience.org/library/genes/1437 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL10 | 3586 | PubTator's text mining | https://conductscience.org/library/genes/3586 | NCBI Gene |
| IL12B | 3593 | PubTator's text mining | https://conductscience.org/library/genes/3593 | NCBI Gene |
| IL4 | 3565 | PubTator's text mining | https://conductscience.org/library/genes/3565 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/27782834
GET https://conductscience.org/api/papers/v1/27782834/references?page=2